Gene: GAGE2B
Official Full Name: G antigen 2Bprovided by HGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO17497 | GAGE2B Knockout cell line (HeLa) | Human | GAGE2B | 1:3~1:6 | Negative | Online Inquiry |
KO17498 | GAGE2B Knockout cell line (HCT 116) | Human | GAGE2B | 1:2~1:4 | Negative | Online Inquiry |
KO17499 | GAGE2B Knockout cell line (HEK293) | Human | GAGE2B | 1:3~1:6 | Negative | Online Inquiry |
KO17500 | GAGE2B Knockout cell line (A549) | Human | GAGE2B | 1:3~1:4 | Negative | Online Inquiry |
GAGE2B Gene Knockout Cell Lines are genetically engineered cell lines that have been selectively modified to deactivate the GAGE2B gene, which is known for its expression in certain types of tumors and immune responses. These cell lines serve as an invaluable tool for researchers investigating the biological roles of GAGE2B in cellular processes, cancer progression, and potential therapeutic pathways. By eliminating the function of this gene, the knockouts provide insights into gene interaction networks and contribute to the understanding of tumor immunology and the development of targeted therapies.
The primary function of GAGE2B Gene Knockout Cell Lines is to facilitate the study of gene function through the observation of resulting phenotypic changes. By comparing knockout cells with their wild-type counterparts, researchers can elucidate the impacts of GAGE2B on various biological pathways, including cell proliferation, apoptosis, and immune modulation. These cell lines are designed to replicate conditions that mirror specific tumor microenvironments, thereby providing a reliable platform for the evaluation of drug efficacy and the mechanistic action of novel treatments.
The scientific importance of GAGE2B Gene Knockout Cell Lines extends into both research and clinical settings, where they are utilized in cancer studies, immunotherapy development, and the validation of new drug candidates. Their applications range from basic cell biology research to translational studies aimed at understanding the intricate interactions within the tumor microenvironment.
A key advantage of our GAGE2B Gene Knockout Cell Lines lies in their precision and reliability, achieved through advanced CRISPR/Cas9 gene-editing techniques, ensuring exact targeting of the gene of interest. Compared to conventional gene silencing methods, such as RNA interference, knockout lines provide a more definitive assessment of gene function without the complications of off-target effects or transient expression.
Researchers and clinicians alike will find GAGE2B Gene Knockout Cell Lines invaluable for advancing their studies into cancer biology and immune responses. Their ability to create robust models for studying gene functions enhances experimental reproducibility and supports the development of effective therapeutic strategies.
At [Your Company Name], we are committed to providing cutting-edge biological products to the research community, backed by years of expertise in gene editing technologies. Our GAGE2B Gene Knockout Cell Lines are a testament to our dedication to empowering researchers with the tools they need to innovate in the field of genetic and cellular research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.